Attitudes and actions of asthma patients on regular maintenance therapy: The INSPIRE study

BMC Pulmonary Medicine

Volumn 6, Issue , 2006, Pages

  Partridge, Martyn R ^a   van der Molen, Thys ^b   Myrseth, Sven Erik ^c   Busse, William W ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c EFA European Federation of Allergy and Airways Diseases Patients' Associations   (Belgium)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; LONG ACTING DRUG; SALMETEROL; SHORT ACTING DRUG;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE EXACERBATION; DRUG USE; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE; SELF CARE; SELF CONCEPT; STRUCTURED INTERVIEW; SYMPTOM; THERAPEUTIC ERROR;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; ATTITUDE TO HEALTH; DRUG THERAPY, COMBINATION; HUMANS; INTERVIEWS AS TOPIC; PATIENT SATISFACTION; QUALITY OF LIFE; SELF CARE;

EID: 33745596102     PISSN: 14712466     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-6-13     Document Type: Article

References (31)

1. Masoli M, Fabian D, Holt S, Beasley R: Global burden of asthma. http//www.ginasthma.com/ReportItem.asp?II=2&12=2&=intld=94]. Accessed 21 June 2005
2. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention (updated 2004) Bethesda MD: National Institutes of Health; NIH Publication No. 02-3659; 2004.
3. National Asthma Education and Prevention Program: Guidelines for the Diagnosis and Management of Asthma Expert Panel Report 2 Bethesda, MD: National Institutes of Health; NHI Publication No. 97-4051; 1997.
4. British Thoracic Society: British guidelines on the management of asthma. Thorax 2003, 58(Suppl 1):1-94.
5. Hyland ME, Ståhl E: Asthma treatment needs: a comparison of patients' and health care professionals' perceptions. Clin Ther 2004, 26:2141-2152.
6. Aubier M, Pieters WR, Schlösser NJJ, Steinmetz K-O: Salmeterol/ fluticasone propionate (50/250 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 1999, 93:876-884.
7. Lalloo UG, Malolepszy J, Kozma D, Krofta K, Ankerst J, Johansen B, Thomson NC: Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest 2003, 123:1480-1487.
8. Zetterström O, Buhl R, Mellem H, Perpina M, Hedman J, O'Neill, Ekstrom T: Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001, 18:262-268.
9. Price D, Ryan D, Pearce L, Bride F: The AIR study: asthma in real life. Asthma J, 1999, 4:74-78.
10. Haughney J, Barnes G, Partridge M, Cleland J: The Living and Breathing Study: a study of patients' views of asthma and its treatments. Primary Care Respiratory Journal 2004, 13:28-35.
11. Rabe KF, Vermeire PA, Soriano JB, Maier WC: Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000, 16:802-807.
12. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST: Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004, 114:40-47.
13. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie DR: Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902-907.
14. Juniper EF, Svensson K, Mork AC, Ståhl E: Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005, 99:553-558.
15. Juniper EF, Bousquet J, Abetz L, Bateman ED, the GOAL Committee: Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med 2006, 100:616-624.
16. Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC: Stepping down inhaled corticosteroids in asthma; randomised controlled trial. BMJ 2003, 326:1115-1120.
17. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, Lofdahl CG, Pauwels RA, Ullman A: Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999, 160:594-599.
18. FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J, for the Canadian Asthma Exacerbation Study Group: Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004, 59:550-556.
19. Harrison TW, Oborne J, Newton S, Tattersfield AE: Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004, 363:271-275.
20. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, Bauman A, Hensley MJ, Walters EH: Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003, I:CD001117.
21. Foresi A, Morelli MC, Catena E: Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. Chest 2000, 117:440-446.
22. FitzGerald JM, Sears MR, Boulet LP, Becker AB, McIvor AR, Ernst P, Smiljanic-Georgijev NM, Lee JS, Canadian Investigators: Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. Can Respir J 2003, 10:427-434.
23. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekstrom T, Bateman ED: Budesonide/formoterol combination therapy as both maintenance and reliever medication. Am J Respir Crit Care Med 2005, 171:129-136.
24. Barnes PJ: A single inhaler for asthma? Am J Respir Crit Care Med 2005, 171:95-96.
25. British Thoracic Society: Guidelines for management of asthma in adults: I-Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ 1990, 301:651-653.
26. Aalbers R, Backer V, Kava TT, Omenaas ER, Sandstrom T, Jorup C, Welte T: Adjustable maintenance dosing with budesonide/ formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin 2004, 20:225-240.
27. Gibson PG, Powell H: Written action plans for asthma: an evidence-based review of the key components. Thorax 2004, 59:94-99.
28. Thoonen BP, Schermer TR, Van Den Boom G, Molema J, Folgering H, Akkermans RP, Grol R, Van Weel C, Van Schayck CP: Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax 2003, 58:30-36.
29. Gallefoss F, Bakke PS: How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med 1999, 160:2000-2005.
30. Sibbald B: Patient self care in acute asthma. Thorax 1989, 44:97-101.
31. Burr ML, Verrall C, Kaur B: Social deprivation and asthma. Respir Med 1997, 91:603-608.